Fluvastatin for reduction of cardiovascular risk in patients with moderate to severe renal insufficiency.

Παρόμοια τεκμήρια

• Niacin for reduction of cardiovascular risk.
  ανά: Landray, M, κ.ά.
  Έκδοση: (2014)
• Niacin for reduction of cardiovascular risk.
  ανά: Landray, M, κ.ά.
  Έκδοση: (2014)
• Evaluate the efficacy of Simvastatin and Fluvastatin in patients with hypercholesterolemia and their effect on liver functions
  ανά: Hassan A. H. Ali, κ.ά.
  Έκδοση: (2017-12-01)
• EFFECTS OF THERAPY ON THE ABILITY OF ERYTHROCYTES FLUVASTATIN AGGREGATION IN HYPERTENSIVE PATIENTS WITH DYSLIPIDEMIA
  ανά: I. N. Medvedev, κ.ά.
  Έκδοση: (2012-03-01)
• FLUVASTATIN EFFECTS ON BLOOD CELL AGGREGATION IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
  ανά: I. N. Medvedev, κ.ά.
  Έκδοση: (2013-04-01)